Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Amortizatization of Intangibles (2017 - 2026)

Cogent Biosciences' Amortizatization of Intangibles history spans 9 years, with the latest figure at $1.2 million for Q1 2026.

  • Quarterly Amortizatization of Intangibles rose 136.95% to $1.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Mar 2026, up 36.85% year-over-year, with the annual reading at $2.0 million for FY2025, 3.21% up from the prior year.
  • Amortizatization of Intangibles came in at $1.2 million for Q1 2026, up from $456000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $6.2 million in Q3 2024 to a low of -$3.1 million in Q4 2024.
  • The 5-year median for Amortizatization of Intangibles is $491000.0 (2022), against an average of $470529.4.
  • The largest YoY upside for Amortizatization of Intangibles was 2162.77% in 2024 against a maximum downside of 1688.78% in 2024.
  • Cogent Biosciences' Amortizatization of Intangibles stood at $1.2 million in 2022, then tumbled by 83.42% to $196000.0 in 2023, then crashed by 1688.78% to -$3.1 million in 2024, then soared by 114.64% to $456000.0 in 2025, then skyrocketed by 158.77% to $1.2 million in 2026.
  • Per Business Quant, the three most recent readings for COGT's Amortizatization of Intangibles are $1.2 million (Q1 2026), $456000.0 (Q4 2025), and $506000.0 (Q3 2025).